A pilot study of Pemetrexed, Platinum agent plus Bevacizumab for advanced non-squamous non-small cell lung cancer with brain metastases

Trial Profile

A pilot study of Pemetrexed, Platinum agent plus Bevacizumab for advanced non-squamous non-small cell lung cancer with brain metastases

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Pemetrexed (Primary) ; Carboplatin; Cisplatin
  • Indications Brain metastases; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Mar 2015 According to the University Hospital Medical Information Network - Japan record, status changed from recruiting to discontinued.
    • 03 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top